Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A03637 | 33923295 | Int J Mol Sci | Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk. | 2021 | Details |
| A03638 | 33923255 | Nutrients | Overview of Non-Alcoholic Fatty Liver Disease (NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development. | 2021 | Details |
| A03639 | 33923175 | Cells | Adipocyte, Immune Cells, and miRNA Crosstalk: A Novel Regulator of Metabolic Dysfunction and Obesity. | 2021 | Details |
| A03640 | 33923083 | Cells | Integrated Action of Autophagy and Adipose Tissue Triglyceride Lipase Ameliorates Diet-Induced Hepatic Steatosis in Liver-Specific PLIN2 Knockout Mice. | 2021 | Details |
| A03641 | 33922278 | Genes (Basel) | The Effect of Genetic Polymorphism in Response to Body Weight Reduction in Japanese Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03642 | 33922256 | Molecules | Exploratory Study Using Urinary Volatile Organic Compounds for the Detection of Hepatocellular Carcinoma. | 2021 | Details |
| A03643 | 33922045 | Molecules | Protective Effect of Cudrania tricuspidata Extract against High-Fat Diet Induced Nonalcoholic Fatty Liver Disease through Nrf-2/HO-1 Pathway. | 2021 | Details |
| A03644 | 33921881 | Int J Mol Sci | Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-A Condition Associated with Heightened Sympathetic Activation. | 2021 | Details |
| A03645 | 33921370 | Int J Environ Res Public Health | Xylo-Oligosaccharides in Prevention of Hepatic Steatosis and Adipose Tissue Inflammation: Associating Taxonomic and Metabolomic Patterns in Fecal Microbiomes with Biclustering. | 2021 | Details |
| A03646 | 33921359 | Diagnostics (Basel) | Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management. | 2021 | Details |
| A03647 | 33921027 | Int J Mol Sci | Iron at the Interface of Hepatocellular Carcinoma. | 2021 | Details |
| A03648 | 33920792 | J Clin Med | Non Alcoholic Fatty Liver Disease Is Positively Associated with Increased Glycated Haemoglobin Levels in Subjects without Diabetes. | 2021 | Details |
| A03649 | 33920751 | Metabolites | Presence and Implications of Sarcopenia in Non-alcoholic Steatohepatitis. | 2021 | Details |
| A03650 | 33920670 | Int J Mol Sci | Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC. | 2021 | Details |
| A03651 | 33919415 | Antioxidants (Basel) | Lyophilized Maqui (Aristotelia chilensis) Berry Administration Suppresses High-Fat Diet-Induced Liver Lipogenesis through the Induction of the Nuclear Corepressor SMILE. | 2021 | Details |
| A03652 | 33919190 | Antioxidants (Basel) | The Impact of H2S on Obesity-Associated Metabolic Disturbances. | 2021 | Details |
| A03653 | 33918878 | Int J Mol Sci | Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions. | 2021 | Details |
| A03654 | 33918467 | Biomedicines | Modeling Diet-Induced NAFLD and NASH in Rats: A Comprehensive Review. | 2021 | Details |
| A03655 | 33918456 | Int J Mol Sci | Relationship between NAFLD and Periodontal Disease from the View of Clinical and Basic Research, and Immunological Response. | 2021 | Details |
| A03656 | 33918059 | J Pers Med | Animal Evidence for Synergistic Induction of Hepatic Injury by Dietary Fat and Alcohol Consumption and Its Potential Mechanisms. | 2021 | Details |
| A03657 | 33917919 | Cancers (Basel) | The rs599839 A>G Variant Disentangles Cardiovascular Risk and Hepatocellular Carcinoma in NAFLD Patients. | 2021 | Details |
| A03658 | 33917875 | Children (Basel) | Associations between Free Sugar and Sugary Beverage Intake in Early Childhood and Adult NAFLD in a Population-Based UK Cohort. | 2021 | Details |
| A03659 | 33917867 | J Clin Med | Interplay between Heart Disease and Metabolic Steatosis: A Contemporary Perspective. | 2021 | Details |
| A03660 | 33917360 | Antioxidants (Basel) | Lingonberry Improves Non-Alcoholic Fatty Liver Disease by Reducing Hepatic Lipid Accumulation, Oxidative Stress and Inflammatory Response. | 2021 | Details |
| A03661 | 33917315 | Cancers (Basel) | The Consumption of Cholesterol-Enriched Diets Conditions the Development of a Subtype of HCC with High Aggressiveness and Poor Prognosis. | 2021 | Details |
| A03662 | 33917049 | Int J Mol Sci | Sex and Race-Related DNA Methylation Changes in Hepatocellular Carcinoma. | 2021 | Details |
| A03663 | 33916843 | Antioxidants (Basel) | Cisd2 Protects the Liver from Oxidative Stress and Ameliorates Western Diet-Induced Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03664 | 33916626 | J Clin Med | Diagnostic Accuracy of Non-Imaging and Ultrasound-Based Assessment of Hepatic Steatosis Using Controlled Attenuation Parameter (CAP) as Reference. | 2021 | Details |
| A03665 | 33915261 | J Nutr Biochem | Consumption of soybean or olive oil at recommended concentrations increased the intestinal microbiota diversity and insulin sensitivity and prevented fatty liver compared to the effects of coconut oil. | 2021 | Details |
| A03666 | 33914974 | Fundam Clin Pharmacol | Changes in digoxin pharmacokinetics associated with hepatic P-glycoprotein upregulation in rats with non-alcoholic fatty liver disease. | 2021 | Details |
| A03667 | 33913796 | J Dermatolog Treat | The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry. | 2022 | Details |
| A03668 | 33913734 | J Altern Complement Med | Chinese Herbal Medicine Decreases Incidence of Cirrhosis in Patients with Non-Alcoholic Fatty Liver Disease in Taiwan: A Propensity Score-Matched Cohort Study. | 2021 | Details |
| A03670 | 33912410 | Tzu Chi Med J | Role of diet and lifestyle modification in the management of nonalcoholic fatty liver disease and type 2 diabetes. | 2020 | Details |
| A03671 | 33912056 | Front Pharmacol | P- Hydroxybenzyl Alcohol Alleviates Oxidative Stress in a Nonalcoholic Fatty Liver Disease Larval Zebrafish Model and a BRL-3A Hepatocyte Via the Nrf2 Pathway. | 2021 | Details |
| A03672 | 33912032 | Front Pharmacol | 5-Bis-(2,6-difluoro-benzylidene) Cyclopentanone Acts as a Selective 11β-Hydroxysteroid Dehydrogenase one Inhibitor to Treat Diet-Induced Nonalcoholic Fatty Liver Disease in Mice. | 2021 | Details |
| A03673 | 33911167 | Sci Rep | Body weight variability and the risk of cardiovascular outcomes in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A03674 | 33909947 | Mol Nutr Food Res | Effects of Insoluble Cereal Fibre on Body Fat Distribution in the Optimal Fibre Trial. | 2021 | Details |
| A03675 | 33909662 | PLoS One | Effect of focused ultrasound cavitation augmented with aerobic exercise on abdominal and intrahepatic fat in patients with non-alcoholic fatty liver disease: A randomized controlled trial. | 2021 | Details |
| A03676 | 33908180 | J Hepatobiliary Pancreat Sci | Machine learning algorithm outperforms fibrosis markers in predicting significant fibrosis in biopsy-confirmed NAFLD. | 2021 | Details |
| A03677 | 33907839 | Int J Mol Med | Role of 2‑series prostaglandins in the pathogenesis of type 2 diabetes mellitus and non‑alcoholic fatty liver disease (Review). | 2021 | Details |
| A03678 | 33907168 | Medicine (Baltimore) | The relationship between non-alcoholic fatty liver disease and hypothyroidism: A systematic review and meta-analysis. | 2021 | Details |
| A03680 | 33905793 | J Hepatol | Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter study. | 2021 | Details |
| A03681 | 33905771 | Clin Gastroenterol Hepatol | A PNPLA3 Polymorphism Confers Lower Susceptibility to Incident Diabetes Mellitus in Subjects With Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03682 | 33903707 | Sci Rep | MicroRNA Let-7 targets AMPK and impairs hepatic lipid metabolism in offspring of maternal obese pregnancies. | 2021 | Details |
| A03683 | 33903148 | Gut | Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug target. | 2021 | Details |
| A03684 | 33902605 | Lipids Health Dis | Elucidation of SIRT-1/PGC-1α-associated mitochondrial dysfunction and autophagy in nonalcoholic fatty liver disease. | 2021 | Details |
| A03685 | 33902194 | Zhonghua Gan Zang Bing Za Zhi | [Study of liver fat and iron deposition quantification based on magnetic resonance imaging in rats with nonalcoholic fatty liver disease]. | 2021 | Details |
| A03686 | 33902193 | Zhonghua Gan Zang Bing Za Zhi | [Phosphonate inhibits steatosis and lobular inflammation of non-alcoholic steatohepatitis through depleting macrophages]. | 2021 | Details |
| A03687 | 33902187 | Zhonghua Gan Zang Bing Za Zhi | [Metabolic-associated fatty liver disease-related liver cirrhosis and cryptogenic liver cirrhosis]. | 2021 | Details |
| A03688 | 33901779 | Ecotoxicol Environ Saf | Dysregulation of autophagy acts as a pathogenic mechanism of non-alcoholic fatty liver disease (NAFLD) induced by common environmental pollutants. | 2021 | Details |
| A03689 | 33901636 | Comp Biochem Physiol C Toxicol Pharmacol | Ameliorative role of ellagic acid against acute liver steatosis in adult zebrafish experimental model. | 2021 | Details |
| A03692 | 33901295 | Hepatology | Functional Characterization of Organoids Derived From Irreversibly Damaged Liver of Patients With NASH. | 2021 | Details |
| A03693 | 33900847 | Am J Physiol Endocrinol Metab | High uric acid induces liver fat accumulation via ROS/JNK/AP-1 signaling. | 2021 | Details |
| A03694 | 33900338 | Food Funct | Myricetin improves metabolic outcomes but not cognitive deficit associated to metabolic syndrome in male mice. | 2021 | Details |
| A03695 | 33900013 | Liver Int | 2021 ISHEN guidelines on animal models of hepatic encephalopathy. | 2021 | Details |
| A03696 | 33899670 | Int J Food Sci Nutr | Dietary isoflavones intake is inversely associated with non-alcoholic fatty liver disease, hyperlipidaemia and hypertension. | 2021 | Details |
| A03697 | 33899443 | Sheng Wu Yi Xue Gong Cheng Xue Za Zhi | [A review on cell-based models of human liver disease in vitro]. | 2021 | Details |
| A03698 | 33899143 | Eur Radiol | Magnetic resonance elastography biomarkers for detection of histologic alterations in nonalcoholic fatty liver disease in the absence of fibrosis. | 2021 | Details |
| A03699 | 33898961 | JHEP Rep | Physical activity is associated with reduced risk of liver disease in the prospective UK Biobank cohort. | 2021 | Details |
| A03700 | 33898960 | JHEP Rep | Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial. | 2021 | Details |
| A03701 | 33898959 | JHEP Rep | Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases. | 2021 | Details |
| A03702 | 33898958 | JHEP Rep | Weight-loss-independent benefits of exercise on liver steatosis and stiffness in Japanese men with NAFLD. | 2021 | Details |
| A03703 | 33897617 | Front Endocrinol (Lausanne) | Mining Gut Microbiota From Bariatric Surgery for MAFLD. | 2021 | Details |
| A03704 | 33897616 | Front Endocrinol (Lausanne) | Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis. | 2021 | Details |
| A03705 | 33897464 | Front Physiol | Free Fatty Acid Receptors as Mediators and Therapeutic Targets in Liver Disease. | 2021 | Details |
| A03706 | 33896439 | Public Health Nutr | Relationship between dietary macronutrient composition and non-alcoholic fatty liver disease in lean and non-lean populations: a cross-sectional study. | 2021 | Details |
| A03707 | 33896117 | Liver Int | Combined analysis of gut microbiota, diet and PNPLA3 polymorphism in biopsy-proven non-alcoholic fatty liver disease. | 2021 | Details |
| A03708 | 33896100 | Liver Int | Definite and indeterminate nonalcoholic steatohepatitis share similar clinical features and prognosis: A longitudinal study of 1893 biopsy-proven nonalcoholic fatty liver disease subjects. | 2021 | Details |
| A03709 | 33895783 | Int J Obes (Lond) | Lampaya Medicinalis Phil. decreases lipid-induced triglyceride accumulation and proinflammatory markers in human hepatocytes and fat body of Drosophila melanogaster. | 2021 | Details |
| A03710 | 33895552 | Biochem Biophys Res Commun | The PDE5 inhibitor udenafil ameliorates nonalcoholic fatty liver disease by improving mitochondrial function. | 2021 | Details |
| A03711 | 33895191 | Pharmacol Ther | The pathophysiological function of non-gastrointestinal farnesoid X receptor. | 2021 | Details |
| A03712 | 33895182 | Metabolism | The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis. | 2021 | Details |
| A03713 | 33895138 | J Biol Chem | Loss of Down syndrome critical region-1 leads to cholesterol metabolic dysfunction that exaggerates hypercholesterolemia in ApoE-null background. | 2021 | Details |
| A03714 | 33894425 | Cell Mol Gastroenterol Hepatol | Caspase-11-Mediated Hepatocytic Pyroptosis Promotes the Progression of Nonalcoholic Steatohepatitis. | 2021 | Details |
| A03715 | 33894178 | Am J Pathol | Inhibition of Estrogen-Related Receptor α Blocks Liver Steatosis and Steatohepatitis and Attenuates Triglyceride Biosynthesis. | 2021 | Details |
| A03716 | 33894145 | Lancet | Non-alcoholic fatty liver disease. | 2021 | Details |
| A03717 | 33894100 | Liver Int | Diagnostic accuracy of fibrosis tests in children with non-alcoholic fatty liver disease: A systematic review. | 2021 | Details |
| A03718 | 33894097 | Liver Int | A nonbile acid farnesoid X receptor agonist tropifexor potently inhibits cholestatic liver injury and fibrosis by modulating the gut-liver axis. | 2021 | Details |
| A03719 | 33894019 | Hepatology | Hepatocyte SH3RF2 Deficiency Is a Key Aggravator for NAFLD. | 2021 | Details |
| A03720 | 33893355 | Sci Rep | Liver fat scores do not reflect interventional changes in liver fat content induced by high-protein diets. | 2021 | Details |
| A03721 | 33892409 | Eur J Cancer | Association between non-alcoholic fatty liver disease and the risk of biliary tract cancers: A South Korean nationwide cohort study. | 2021 | Details |
| A03722 | 33892169 | Mol Metab | Metabolic-associated fatty liver disease and lipoprotein metabolism. | 2021 | Details |
| A03723 | 33892010 | J Hepatol | Disease-specific eQTL screening reveals an anti-fibrotic effect of AGXT2 in non-alcoholic fatty liver disease. | 2021 | Details |
| A03725 | 33891332 | FASEB J | Silencing of STE20-type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet-induced nonalcoholic fatty liver disease. | 2021 | Details |
| A03726 | 33889834 | Metabol Open | Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study. | 2021 | Details |
| A03727 | 33889132 | Front Endocrinol (Lausanne) | Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes. | 2021 | Details |
| A03728 | 33889015 | Int J Gen Med | Correlation of Serum Transaminase Levels with Liver Fibrosis Assessed by Transient Elastography in Vietnamese Patients with Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03729 | 33887577 | Int Immunopharmacol | Neutrophil: An emerging player in the occurrence and progression of metabolic associated fatty liver disease. | 2021 | Details |
| A03730 | 33887358 | J Hepatol | Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis. | 2021 | Details |
| A03731 | 33887125 | United European Gastroenterol J | Gut fermentation syndrome: A systematic review of case reports. | 2021 | Details |
| A03732 | 33885128 | Food Funct | Modulation of the fecal microbiome and metabolome by resistant dextrin ameliorates hepatic steatosis and mitochondrial abnormalities in mice. | 2021 | Details |
| A03733 | 33885048 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | Effect of bariatric surgery on fatty liver disease in obese patients: A prospective one year follow-up study. | 2021 | Details |
| A03734 | 33883996 | Int J Endocrinol | Circulating Prokineticin 2 Levels Are Increased in Children with Obesity and Correlated with Insulin Resistance. | 2021 | Details |
| A03735 | 33883636 | Sci Rep | Fatty liver index is independently associated with deterioration of renal function during a 10-year period in healthy subjects. | 2021 | Details |
| A03736 | 33883616 | Sci Rep | Non-alcoholic fatty liver disease is associated with bacterial translocation and a higher inflammation response in psoriatic patients. | 2021 | Details |
| A03737 | 33883445 | Curr Opin Lipidol | Nonalcohol fatty liver disease: balancing supply and utilization of triglycerides. | 2021 | Details |
| A03738 | 33883285 | Endocr Connect | Activation of heat shock response improves biomarkers of NAFLD in patients with metabolic diseases. | 2021 | Details |
| A03739 | 33883248 | Gut | Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease. | 2021 | Details |
| A03740 | 33882758 | Expert Rev Clin Pharmacol | Effects of anti-diabetic treatments in type 2 diabetes and fatty liver disease. | 2021 | Details |
| A03741 | 33882107 | PLoS One | What proportion of people have a follow-up biopsy in randomized trials of treatments for non-alcoholic steatohepatitis?: A systematic review and meta-analysis. | 2021 | Details |